(Correcting the description of the company in the third paragraph)
China Resources Medical (HKG:1515) recorded a rise in attributable profit for the year 2024 to 565.9 million yuan from 257.7 million yuan a year prior, a Tuesday filing with the Hong Kong bourse said.
Earnings per share were 0.45 yuan in the year, up from 0.20 yuan in the last fiscal year.
The hospital business firm's revenue fell to 9.85 billion yuan in the period from 10.1 billion yuan a year prior.
The company has proposed a final dividend of 0.082 yuan per share for the year, payable on or before July 21 to shareholders of record on June 12.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。